SBIO vs. DBO
SBIO (ALPS Medical Breakthroughs ETF) and DBO (Invesco DB Oil Fund) are both exchange-traded funds - SBIO is a Health & Biotech Equities fund tracking the S-Network Medical Breakthroughs Index, while DBO is a Oil & Gas fund tracking the DBIQ Optimum Yield Crude Oil Index Excess Return. Both are passively managed. Over the past 10 years, SBIO returned 10.42%/yr vs 11.43%/yr for DBO. Their 0.10 correlation means their historical movements had little consistent relationship. SBIO charges 0.50%/yr vs 0.78%/yr for DBO.
Performance
SBIO vs. DBO - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, SBIO achieves a 24.03% return, which is significantly lower than DBO's 66.72% return. Over the past 10 years, SBIO has underperformed DBO with an annualized return of 10.42%, while DBO has yielded a comparatively higher 11.43% annualized return.
SBIO
- 1D
- 0.26%
- 1M
- -2.12%
- 6M
- 20.98%
- YTD
- 24.03%
- 1Y
- 94.30%
- 3Y*
- 28.61%
- 5Y*
- 8.57%
- 10Y*
- 10.42%
- ALL TIME*
- 9.15%
DBO
- 1D
- -5.53%
- 1M
- 17.71%
- 6M
- 53.16%
- YTD
- 66.72%
- 1Y
- 51.44%
- 3Y*
- 12.33%
- 5Y*
- 13.64%
- 10Y*
- 11.43%
- ALL TIME*
- 0.22%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $11.34M | $10.71M | $13.49M | |
| $2.14M | $3.25M | $2.22M |
SBIO vs. DBO - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
SBIO ALPS Medical Breakthroughs ETF | 24.03% | 55.07% | 3.81% | 8.68% | -28.08% | -17.55% | 21.17% | 50.30% | -11.81% | 45.67% |
DBO Invesco DB Oil Fund | 66.72% | -11.71% | 7.85% | -4.44% | 13.04% | 60.74% | -20.99% | 28.05% | -15.22% | 4.86% |
Correlation
The correlation between SBIO and DBO is -0.24, meaning they have often moved in opposite directions in the past. This relationship can weaken or reverse as market conditions change.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | -0.24 |
Correlation (3Y) Balances recent behavior with more history. | -0.11 |
Correlation (5Y) Shows whether the relationship held over a longer period. | -0.02 |
Correlation (10Y) Provides a long-term view across more market conditions. | 0.09 |
Correlation (All Time) Calculated using the full available price history since Dec 31, 2014 | 0.10 |
The correlation between SBIO and DBO shifts across timeframes, from -0.24 (1 year) to 0.10 (all time), reflecting how their relationship changes across market environments.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
SBIO vs. DBO — Risk / Return Rank
SBIO
DBO
SBIO vs. DBO - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for ALPS Medical Breakthroughs ETF (SBIO) and Invesco DB Oil Fund (DBO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| SBIO | DBO | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.72 | ||
| Sortino ratioReturn per unit of downside risk | +1.92 | ||
| Omega ratioGain probability vs. loss probability | 1.45 | 1.23 | +0.22 |
| Calmar ratioReturn relative to maximum drawdown | 7.49 | 1.86 | +5.63 |
| Martin ratioReturn relative to average drawdown | 19.63 | 5.64 | +13.98 |
Loading charts...
Drawdowns
SBIO vs. DBO - Drawdown Comparison
The maximum SBIO drawdown since its inception was -63.06%, smaller than the maximum DBO drawdown of -90.18%. Use the drawdown chart below to compare losses from any high point for SBIO and DBO.
Loading charts...
Drawdown Indicators
| SBIO | DBO | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -63.06% | -90.18% | +27.12% |
Max Drawdown (1Y)Largest decline over 1 year | -12.66% | -27.73% | +15.07% |
Max Drawdown (3Y)Largest decline over 3 years | -42.44% | -28.20% | -14.24% |
Max Drawdown (5Y)Largest decline over 5 years | -52.49% | -37.68% | -14.81% |
Max Drawdown (10Y)Largest decline over 10 years | -63.06% | -61.69% | -1.37% |
Current DrawdownCurrent decline from peak | -7.85% | -56.13% | +48.28% |
Average DrawdownAverage peak-to-trough decline | -28.13% | -62.20% | +34.07% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.82% | 9.16% | -4.34% |
Volatility
SBIO vs. DBO - Volatility Comparison
The current volatility for ALPS Medical Breakthroughs ETF (SBIO) is 9.73%, while Invesco DB Oil Fund (DBO) has a volatility of 18.99%. This indicates that SBIO experiences smaller price fluctuations and is considered to be less risky than DBO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| SBIO | DBO | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 9.73% | 18.99% | -9.26% |
Volatility (6M)Calculated over the trailing 6-month period | 24.05% | 34.30% | -10.25% |
Volatility (1Y)Calculated over the trailing 1-year period | 31.08% | 38.86% | -7.78% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 33.88% | 33.43% | +0.45% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 33.19% | 32.24% | +0.95% |
SBIO vs. DBO - Expense Ratio Comparison
SBIO has a 0.50% expense ratio, which is lower than DBO's 0.78% expense ratio.
Dividends
SBIO vs. DBO - Dividend Comparison
SBIO has not paid dividends to shareholders, while DBO's dividend yield for the trailing twelve months is around 2.11%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
DBO Invesco DB Oil Fund | 2.11% | 3.51% | 4.68% | 4.59% | 0.66% | 0.00% | 0.00% | 1.63% | 1.58% | 0.00% |
SBIO ALPS Medical Breakthroughs ETF | 0.00% | 0.00% | 3.55% | 0.22% | 0.00% | 0.00% | 0.00% | 0.04% | 2.79% | 1.77% |
Frequently Asked Questions
SBIO and DBO have a correlation of -0.24, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
DBO has higher volatility (18.99%) compared to SBIO (9.73%). In terms of maximum drawdown, SBIO dropped -63.06% vs DBO's -90.18%.
On 10-year performance, DBO leads with 11.43% vs 10.42% for SBIO. On fees, SBIO is cheaper at 0.50% per year. On volatility, SBIO has been the lower-risk option at 9.73%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 10-year period, DBO has performed better with a 11.43% return vs 10.42%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
SBIO is cheaper with a 0.50% expense ratio, compared with 0.78% for DBO.
DBO has the higher dividend yield at 2.11%, compared with 0.00% for SBIO.
SBIO is categorized as Health & Biotech Equities, while DBO is Oil & Gas. SBIO tracks S-Network Medical Breakthroughs Index, while DBO tracks DBIQ Optimum Yield Crude Oil Index Excess Return. They also come from different issuers: SS&C and Invesco. Their fees differ too: 0.50% for SBIO and 0.78% for DBO.
SBIO currently has the higher Sharpe Ratio (3.06 vs 1.33), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for SBIO and DBO
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer